Literature DB >> 7473165

Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice.

J Liu1, Y Liu, A Parkinson, C D Klaassen.   

Abstract

We have previously shown that oleanolic acid (OA) protects mice against the hepatotoxicity of carbon tetrachloride, acetaminophen, bromobenzene, thioacetamide, furosemide, phalloidin, colchicine, cadmium, D-galactosamine and endotoxin. This study was designed to examine whether OA modulates hepatic toxicant-activating and detoxifying systems as a means of protection. Mice were treated with OA (100 and 200 mumol/kg s.c.) for 3 days, and liver microsomes and cytosols were prepared 24 hr after the last dose. OA produced a dose-dependent reduction in liver microsomal cytochrome P450 (P450) levels (25-37%) and cytochrome b5 (15-21%) content, but had no effect on NADPH-cytochrome c reductase activity. OA treatment also decreased several P450 enzyme activities, such as coumarin 7-hydroxylation (45%), 7-pentoxyresorufin O-dealkylation (35%), 7-ethoxyresorufin O-dealkylation (25%) and chlorzoxazone 6-hydroxylation (20%). Treatment of mice with OA decreased caffeine N3-demethylation (40%), but had no effect on caffeine 8-hydroxylation. OA treatment decreased testosterone 6 alpha- and 15 alpha-hydroxylation (40-50%) and androstenedione formation (35%), but slightly increased testosterone 1 alpha/beta-, 2 beta- and 6 beta-hydroxylation. Consistent with enzyme activities, OA decreased the amounts of mouse liver CYP1A and CYP2A enzymes, but had no appreciable effect on CYP3A enzymes, as determined by immunoblotting with antibodies against rat P450 enzymes. OA treatment slightly increased liver glutathione (GSH) content and the activity of GSH S-transferases toward 1-chloro-2,4-dinitrobenzene, but had no effect on GSH peroxidase and GSH reductase. The activities of superoxide dismutase and DT-diaphorase were unaffected by OA treatment. At the high dose of OA, catalase activity was decreased by 20%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473165

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis.

Authors:  Li Chen; Yihua Zhang; Xiangwen Kong; Sixun Peng; Jide Tian
Journal:  Bioorg Med Chem Lett       Date:  2007-03-25       Impact factor: 2.823

2.  CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.

Authors:  Scott A Reisman; David B Buckley; Yuji Tanaka; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-20       Impact factor: 4.219

3.  Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.

Authors:  Tom Hsun-Wei Huang; Gang Peng; Bhavani Prasad Kota; George Qian Li; Johji Yamahara; Basil D Roufogalis; Yuhao Li
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid.

Authors:  Wenji Li; Surajit Das; Ka-yun Ng; Paul W S Heng
Journal:  Pharm Res       Date:  2011-04-09       Impact factor: 4.200

Review 5.  Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver.

Authors:  Curtis D Klaassen; Scott A Reisman
Journal:  Toxicol Appl Pharmacol       Date:  2010-02-01       Impact factor: 4.219

6.  Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes.

Authors:  Scott A Reisman; Lauren M Aleksunes; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2009-04-01       Impact factor: 5.858

7.  Ficus hispida Linn.: A review of its pharmacognostic and ethnomedicinal properties.

Authors:  Mohammad Ali; Nisha Chaudhary
Journal:  Pharmacogn Rev       Date:  2011-01

8.  Modulation of CYP1A1 and CYP1A2 hepatic enzymes after oral administration of Chios mastic gum to male Wistar rats.

Authors:  Efrosini S Katsanou; Katerina Kyriakopoulou; Christina Emmanouil; Nikolas Fokialakis; Alexios-Leandros Skaltsounis; Kyriaki Machera
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

9.  H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation.

Authors:  Fu-Ming Tsai; Mao-Liang Chen; Lu-Kai Wang; Ming-Cheng Lee
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

10.  Protective effects of pretreatment with oleanolic acid in rats in the acute phase of hepatic ischemia-reperfusion injury: role of the PI3K/Akt pathway.

Authors:  Bo Gui; Fuzhou Hua; Jie Chen; Zeping Xu; Hongbin Sun; Yanning Qian
Journal:  Mediators Inflamm       Date:  2014-04-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.